Drug-resistant hypertensive patients responding to multielectrode renal denervation exhibit improved heart rate dynamics and reduced arrhythmia burden

Journal of Human Hypertension

Volumn 28, Issue 10, 2014, Pages 587-593

  Tsioufis, C ^a   Papademetriou, V ^b   Tsiachris, D ^a   Dimitriadis, K ^a   Kasiakogias, A ^a   Kordalis, A ^a   Antonakis, V ^a   Kefala, A ^a   Thomopoulos, C ^a   Kallikazaros, I ^a   Lau, E O Y ^c   Stefanadis, C ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c St Jude Medical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; POTASSIUM;

ABLATION CATHETER; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ATRIUM ARRHYTHMIA; HEART RATE VARIABILITY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE CONTRACTION; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; KIDNEY DENERVATION; KIDNEY DENERVATION SYSTEM; KIDNEY FUNCTION; MALE; MIDDLE AGED; MULTIELECTRODE RENAL DENERVATION; POTASSIUM BLOOD LEVEL; RESISTANT HYPERTENSION; SUPRAVENTRICULAR TACHYCARDIA; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; ARRHYTHMIAS, CARDIAC; BLOOD; BLOOD PRESSURE; DRUG RESISTANCE; ELECTRODE; HEART RATE; HYPERTENSION; INNERVATION; KIDNEY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SYMPATHECTOMY;

AGED; ARRHYTHMIAS, CARDIAC; BLOOD PRESSURE; DRUG RESISTANCE; ELECTRODES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; POTASSIUM; SYMPATHECTOMY;

EID: 84926176563     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2014.14     Document Type: Article

References (35)

1. Palatini P, Benetos A, Grassi G, Julius S, Kjeldsen SE, Mancia G et al. European Society of Hypertension. Identification and management of the hypertensive patient with elevated heart rate statement of a European Society of Hypertension Consensus Meeting. J Hypertens 2006; 24: 603-610.
2. Hozawa A, Inoue R, Ohkubo T, Kikuya M, Metoki H, Asayama K et al. Predictive value of ambulatory heart rate in the Japanese general population: the Ohasama study. J Hypertens 2008; 26: 1571-1576.
3. Messerli FH, Ventura HO, Elizardi DJ, Dunn FG, Frohlich ED. Hypertension and sudden death: increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 1984; 77: 18-22.
4. Manolis AJ, Rosei EA, Coca A, Cifkova R, Erdine SE, Kjeldsen S et al. Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension. J Hypertens 2012; 30(2): 239-252.
5. Schwarz PJ, Priori SG. Sympathetic nervous system and cardiac arrhythmias. In: Zipes DP, Jalife J (eds.) Cardiac Electrophysiology. From Cell to Bedside. WB Saunders Co: Philadelphia, PA, USA, 1990, pp 330-343.
6. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93: 1043-1065.
7. Singh JP, Larson MG, Tsuji H, Evans JC, O'Donnell CJ, Levy D. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension 1998; 32: 293-297.
8. Schroeder EB, Liao D, Chambless LE, Prineas RJ, Evans GW, Heiss G. Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Hypertension 2003; 42: 1106-1111.
9. Malerba M, Muiesan ML, Zulli R, Rizzoni D, Calebich S, Agabiti Rosei E. Ventricular arrhythmias and changes in blood pressure and left ventricular mass induced by antihypertensive treatment in hypertensive patients. J Hypertens 1991; 9(Suppl 6): S162-S164.
10. Krum H, Schlaich M, Whitburn R, Sobotka PA, Sadowski J, Bartus K et al. Catheterbased renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275-1281.
11. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatmentresistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376: 1903-1909.
12. Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K et al. ESH position paper: renal denervation-an interventional therapy of resistant hypertension. J Hypertens 2012; 30(5): 837-841.
13. Mahfoud F, Lü scher TF, Andersson B, Baumgartner I, Cifkova R, Dimario C et al. Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J 2013; 34(28): 2149-2157.
14. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 2009; 54: 690-697.
15. Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW et al. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension 2013; 61(2): 457-464.
16. Zhao Q, Yu S, Zou M, Dai Z, Wang X, Xiao J et al. Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing. J Interv Card Electrophysiol 2012; 35: 119-125.
17. Worthley SG, Papademetriou V, Worthley MI, Sinhal A, Chew DP, Meredith IT et al. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I Trial. Eur Heart J 2013; 34(28): 2132-2140.
18. Lown B, Wolf M. Approaches to sudden death from coronary heart disease. Circulation 1971; 44: 130-142.
19. Williams B, Lacy PS. CAFE and ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) Investigators. Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFÉ Heart Rate. J Am Coll Cardiol 2009; 54: 705-713.
20. Bangalore S, Sawhney S, Messerli FH. Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension. J Am Coll Cardiol 2008; 52(18): 1482-1489.
21. Julius S, Palatini P, Kjeldsen SE, Zanchetti A, Weber MA, McInnes GT et al. Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension. Am J Cardiol 2012; 109(5): 685-692.
22. Okin PM, Kjeldsen SE, Julius S, Hille DA, Dahlö f B, Devereux RB. Effect of changing heart rate during treatment of hypertension on incidence of heart failure. Am J Cardiol 2012; 109(5): 699-7044.
23. Ukena C, Mahfoud F, Spies A, Kindermann I, Linz D, Cremers B et al. Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension. Int J Cardiol 2013; 167(6): 2846-2851.
24. Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K et al. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension 2012; 60: 172-178.
25. Linz D, Hohl M, Nickel A, Mahfoud F, Wagner M, Ewen S et al. Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea. Hypertension 2013; 62(4): 767-774.
26. Linz D, Mahfoud F, Schotten U, Ukena C, Hohl M, Neuberger HR et al. Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation. Hypertension 2013; 61(1): 225-231.
27. Linz D, Wirth K, Ukena C, Mahfoud F, Pöss J, Linz B et al. Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs. Heart Rhythm 2013; 10(10): 1525-1530.
28. Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Böhm M et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 2012; 59(10): 901-909.
29. Bigger Jr JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol 1992; 69: 891-898.
30. Parati G, Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J 2012; 33(9): 1058-1066.
31. Kleiger RE, Stein PK, Bigger Jr JT. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol 2005; 10(1): 88-101.
32. Lin JL, Chan HL, Du CC, Lin IN, Lai CW, Lin KT et al. Long-term beta-blocker therapy improves autonomic nervous regulation in advanced congestive heart failure: a longitudinal heart rate variability study. Am Heart J 1999; 137: 658-665.
33. Heusser K, Tank J, Engeli S, Diedrich A, Menne J, Eckert S et al. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 2010; 55: 619-626.
34. Himmel F, Weil J, Reppel M, Mortensen K, Franzen K, Ansgar L et al. Improved heart rate dynamics in patients undergoing percutaneous renal denervation. J Clin Hypertens (Greenwich) 2012; 14(9): 654-655.
35. Brinkmann J, Heusser K, Schmidt BM, Menne J, Klein G, Bauersachs J et al. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series. Hypertension 2012; 60(6): 1485-1490.